Multiple New Studies Demonstrate T2 Biosystems’ Diagnostics Improve Detection of Sepsis Causing Pathogens Over Blood Culture-based Diagnostics
T2 Biosystems, Inc. (TTOO)
Last t2 biosystems, inc. earnings: 2/24 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.t2biosystems.com/phoenix.zhtml?c=253528&p=irol-faq
Company Research
Source: GlobeNewswire
LEXINGTON, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products, announces the publication of four new, peer-reviewed studies that demonstrate the clinical and performance advantages of the T2Dx® Instrument over blood culture. The T2Dx Instrument runs the T2Candida® and T2Bacteria® Panels, which detect and identify pathogens that cause sepsis. Sepsis is a life-threatening illness that kills 250,000 Americans and an estimated 6 million people globally each year, and is the most expensive hospital-treated condition in the U.S., with costs exceeding $27 billion. The studies were conducted in the United States and Europe and all published today in the Journal of Antimicrobial Chemotherapy. A study conducted at Gemelli Hospital in Rome, Italy, reported several highlights regarding usage of the T2Bacteria Panel on the T2Dx Instrument: Positive
Show less
Read more
Impact Snapshot
Event Time:
TTOO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TTOO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TTOO alerts
High impacting T2 Biosystems, Inc. news events
Weekly update
A roundup of the hottest topics
TTOO
News
- T2 Biosystems shareholders vote to convert $15M CRG debt into equity [Seeking Alpha]Seeking Alpha
- T2 Biosystems Shareholders Vote for CRG Debt Conversion into EquityGlobeNewswire
- T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. [Yahoo! Finance]Yahoo! Finance
- T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.GlobeNewswire
- T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates [Yahoo! Finance]Yahoo! Finance
TTOO
Sec Filings
- 4/19/24 - Form SC
- 4/18/24 - Form 8-K
- 4/16/24 - Form 4
- TTOO's page on the SEC website